Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories

Labs processing ~2,000 to 5,000 tests a day can finally enjoy the benefits of Total Laboratory Automation (TLA) with a compact workflow-automation solution that fits needs

BREA, CALIF., MAY. 4, 2021 — Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day.

The clinical laboratory has gone through trial by fire in 2020, where total testing was 245% of baseline volumes, with ~55% being SARS-CoV-2 molecular tests1. According to the CDC, an estimated 41% of U.S. adults delayed or avoided medical care2. Despite vaccines, many industry players suggest SARS-CoV-2 testing volumes won’t be impacted in the near term, and the demand for COVID-19-related testing will continue through 2021 and potentially into 20223. This means that testing-volume pressure on labs is going to continue.

Labs of all sizes are facing the same challenges: shortage of laboratory technologists and technicians4, historic financial pressures on hospitals and health systems5, and physically and mentally exhausted laboratory professionals6; – a pre-pandemic problem that has since been exacerbated. However, the TLA solutions that cater to labs processing high-sample volumes are out of reach for smaller volume labs due to space requirements and infrastructure constraints.
"From its compact footprint and minimizing manual work by 80%, to intelligent routing that makes sure our acute patients get their results faster than routine ones, the DxA 5000 Fit was just the right fit for us."
Afruj Ruf
Managing Director
Integrated Pathology Solutions LLP, Airedale NHS Foundation Trust

About Beckman Coulter
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology and the passion and creativity of our teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics and unlocking hidden value through performance partnership. An operating company of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place.

1Bonislawski, A. "The Clinical Lab in 2020: The Impact of COVID-19 This Year and Beyond." 360 Dx. December 29, 2020. [Accessed: March 1, 2021]
2Czeisler MÉ, Marynak K, Clarke KE, et al. Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020. MMWR Morb Mortal Wkly Rep 2020;69:1250–1257. DOI:
3Bonislawski, A. "How Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?" 360 Dx. December 20, 2020. [Accessed: January 28, 2021]
4Ford BA & McElavania E. "Machine Learning Takes Laboratory Automation to the Next Level." Journal of Clinical Microbiology. Mar 2020, 58 (4) e00012-20; DOI: 10.1128/JCM.00012-20
5Hospitals and Health Systems Face Unprecedented Financial Pressures Due to COVID-19. May 2020. American Hospital Association. [Accessed: March 1, 2021]
6 [Accessed: March 1, 2021]
7National Health System Crisis Readiness Report 2020 Edition. Accumen. August 27, 2020. [Accessed October 6, 2020]
8Gramz, J. "The benefits of lab automation to facilitate testing for SARS-CoV-2." November 19, 2020. [Accessed: March 1, 2021]
9Based on Beckman Coulter analysis of typical clinical diagnostics laboratory workflow steps. Step counts may vary.